Xu AJ - Search Results

1

Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.

Han J, Han ML, Xing H, Li ZL, Yuan DY, Wu H, Zhang H, Wang MD, Li C, Liang L, Song YY, Xu AJ, Wu MC, Shen F, Xie Y, Yang T. Han J, et al. Among authors: xu aj. Int J Cancer. 2020 Mar 15;146(6):1741-1753. doi: 10.1002/ijc.32599. Epub 2019 Aug 13. Int J Cancer. 2020. PMID: 31361910

2

Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Han J, Qin WX, Li ZL, Xu AJ, Xing H, Wu H, Zhang H, Wang MD, Li C, Liang L, Quan B, Yan WT, Shen F, Wu MC, Yang T. Han J, et al. Among authors: xu aj. Clin Chim Acta. 2019 Jan;488:68-75. doi: 10.1016/j.cca.2018.10.039. Epub 2018 Oct 31. Clin Chim Acta. 2019. PMID: 30389456

3

Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.

Liu W, Wu J, Yang F, Ma L, Ni C, Hou X, Wang L, Xu A, Song J, Deng Y, Xian L, Li Z, Wang S, Chen X, Yin J, Han X, Li C, Zhao J, Cao G. Liu W, et al. Clin Cancer Res. 2019 Sep 15;25(18):5525-5536. doi: 10.1158/1078-0432.CCR-18-3083. Epub 2019 May 31. Clin Cancer Res. 2019. PMID: 31152021

4

Chronological changes of viral shedding in adult inpatients with Omicron infection in Shanghai, China.

Zhou X, Huang X, Sun T, Jin X, Tian Z, Xue M, Kang J, Gao B, Xu A, Chen Y, Jia Y, Liu S. Zhou X, et al. Front Immunol. 2023 Feb 1;14:1090498. doi: 10.3389/fimmu.2023.1090498. eCollection 2023. Front Immunol. 2023. PMID: 36817453 Free PMC article.

5

Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191)).

Liu Y, Liao W, Xu A, Yin W, Yu J, Fan W, Xue J, Liang X. Liu Y, et al. J Infect. 2022 Apr;84(4):e10-e12. doi: 10.1016/j.jinf.2022.01.035. Epub 2022 Feb 1. J Infect. 2022. PMID: 35120973 No abstract available.

6

Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir.

Liu Y, Ge L, Fan S, Xu A, Wang X, Dong X, Xu M, Fan W, Zhong W, Liang X. Liu Y, et al. Infect Dis Ther. 2022 Dec;11(6):2241-2251. doi: 10.1007/s40121-022-00716-7. Epub 2022 Oct 30. Infect Dis Ther. 2022. PMID: 36310337 Free PMC article.

7

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial.

Liu Y, Fan S, Xu A, Ge L, Wang X, Dong X, Xu M, Fan W, Zhong W, Liang X. Liu Y, et al. Front Pharmacol. 2023 Nov 16;14:1197671. doi: 10.3389/fphar.2023.1197671. eCollection 2023. Front Pharmacol. 2023. PMID: 38034986 Free PMC article.

8

Future directions in transmasculine genital gender-affirming surgery: tissue substitutes and transplant.

Xu AJ, Zeki JA, Khouri J, Mishra K, Gupta S. Xu AJ, et al. Curr Opin Urol. 2024 Oct 24. doi: 10.1097/MOU.0000000000001239. Online ahead of print. Curr Opin Urol. 2024. PMID: 39444270

9

Advances in surface plasmon resonance for analyzing active components in traditional Chinese medicine.

Xie J, Li XD, Li M, Zhu HY, Cao Y, Zhang J, Xu AJ. Xie J, et al. Among authors: xu aj. J Pharm Anal. 2024 Oct;14(10):100983. doi: 10.1016/j.jpha.2024.100983. Epub 2024 Apr 26. J Pharm Anal. 2024. PMID: 39411582 Free PMC article. Review.

10

A Qualitative Exploration of Sacred Moments in Radiation Oncology.

Saint K, Ehrlinger R, Gilliland J, Barton MF, Xu AJ, Santos PMG, Yerramilli D. Saint K, et al. Among authors: xu aj. Adv Radiat Oncol. 2024 Aug 26;9(11):101617. doi: 10.1016/j.adro.2024.101617. eCollection 2024 Nov. Adv Radiat Oncol. 2024. PMID: 39403094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters